Endocrine therapy and urogenital outcomes among women with a breast cancer diagnosis

被引：0
|
作者：
Suzanne N. Landi
Kemi M. Doll
Jeannette T. Bensen
Laura Hendrix
Carey K. Anders
Jennifer M. Wu
Hazel B. Nichols
机构：
[1] University of North Carolina at Chapel Hill,Department of Epidemiology, Gillings School of Global Public Health
[2] University of North Carolina at Chapel Hill,Department of Health Policy and Management, Gillings School of Global Public Health
[3] University of North Carolina at Chapel Hill,Lineberger Comprehensive Cancer Center, School of Medicine
[4] University of North Carolina at Chapel Hill,Department of Obstetrics and Gynecology, School of Medicine
来源：
Cancer Causes & Control | 2016年 / 27卷
关键词：
Endocrine therapy; Cancer survivors; Patient-reported outcomes; Urinary incontinence; Sexual function;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1325 / 1332
页数：7
相关论文
共 50 条
  • [1] Endocrine therapy and urogenital outcomes among women with a breast cancer diagnosis
    Landi, Suzanne N.
    Doll, Kemi M.
    Bensen, Jeannette T.
    Hendrix, Laura
    Anders, Carey K.
    Wu, Jennifer M.
    Nichols, Hazel B.
    [J]. CANCER CAUSES & CONTROL, 2016, 27 (11) : 1325 - 1332
  • [2] Urogenital disorders in women with adjuvant endocrine therapy after early breast cancer
    Baumgart, Juliane
    Nilsson, Kerstin
    Stavreus-Evers, Anneli
    Kask, Kristiina
    Villman, Kenneth
    Lindman, Henrik
    Kallak, Theodora
    Sundstroem-Poromaa, Inger
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2011, 204 (01) : 26.e1 - 26.e7
  • [3] The prevalence and severity of urogenital symptoms in postmenopausal women receiving endocrine therapy for breast cancer
    Chin, S. N.
    Trinkaus, M. E.
    Simmons, C.
    Flynn, C.
    Bolivar, R.
    Clemons, M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [4] Prevalence and Severity of Urogenital Symptoms in Postmenopausal Women Receiving Endocrine Therapy for Breast Cancer
    Chin, Sheray N.
    Trinkaus, Mateya
    Simmons, Christine
    Flynn, Candi
    Dranitsaris, George
    Bolivar, Robyn
    Clemons, Mark
    [J]. CLINICAL BREAST CANCER, 2009, 9 (02) : 108 - 117
  • [5] COPING AND ENDOCRINE THERAPY ADHERENCE AMONG WOMEN WITH BREAST CANCER
    Bright, Emma E.
    Stanton, Annette L.
    [J]. ANNALS OF BEHAVIORAL MEDICINE, 2017, 51 : S89 - S89
  • [6] Symptoms and Symptom Attribution Among Women on Endocrine Therapy for Breast Cancer
    Rosenberg, Shoshana M.
    Stanton, Annette L.
    Petrie, Keith J.
    Partridge, Ann H.
    [J]. ONCOLOGIST, 2015, 20 (06): : 598 - 604
  • [7] BARRIERS TO AND FACILITATORS OF ENDOCRINE THERAPY ADHERENCE AMONG WOMEN WITH BREAST CANCER
    Bright, Emma E.
    Stanton, Annette L.
    Petrie, Keith J.
    [J]. ANNALS OF BEHAVIORAL MEDICINE, 2016, 50 : S290 - S290
  • [8] Adjuvant endocrine therapy and risk of contralateral breast cancer among a cohort of US women with breast cancer
    Gierach, G. L.
    Curtis, R. E.
    Pfeiffer, R. M.
    Mullooly, M.
    Hoover, R. N.
    Nyante, S. J.
    Feigelson, H. S.
    Glass, A. G.
    de Gonzalez, A. Berrington
    [J]. CANCER RESEARCH, 2016, 76
  • [9] The development of endocrine therapy for women with breast cancer
    Sainsbury, Richard
    [J]. CANCER TREATMENT REVIEWS, 2013, 39 (05) : 507 - 517
  • [10] Barriers to and facilitative processes of endocrine therapy adherence among women with breast cancer
    Bright, Emma E.
    Petrie, Keith J.
    Partridge, Ann H.
    Stanton, Annette L.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2016, 158 (02) : 243 - 251
12345